OTC (Self-Test Kit), antigen test for COVID-19 virus in human nasal swab specimens. Approved by Korea MFDS for domestic use, authorized by US FDA EUA.
MFDS certified
US FDA EUA authorized
CE certified
Fast results within 20 minutes
Easy and simple to use
Compact kit optimized for Point Of Care testing
No additional equipment or procedures needed
High diagnostic accuracy
Cost-effective and suitable for mass testing
COVID-19 caused by the SARS-CoV-2 virus is a novel respiratory infectious disease that was declared a pandemic by the World Health Organization (WHO) in March 2020. Symptoms vary but commonly include fatigue, high fever, and cough; in severe cases, it can lead to breathing difficulties and significant lung damage. Although molecular testing (PCR) is the gold standard for COVID-19 diagnosis, it has limitations such as dependence on precise extraction technology, analysis time over six hours, expensive equipment, and the need for highly trained professionals. Therefore, rapid antigen tests that are simple, convenient, and suitable for immediate on-site testing have been widely adopted in advanced countries, including the United States, Japan, and Europe, and are broadly used for infection control. The GenBody COVID-19 Ag product is a rapid immunoassay that qualitatively detects the antigen of the SARS-CoV-2 virus causing COVID-19, using samples collected with swabs from the human nasopharynx or oropharynx.